SciELO - Scientific Electronic Library Online

 
vol.44 issue4Compliance to drug therapy in inflammatory bowel diseases outpatients from an university hospital author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Arquivos de Gastroenterologia

Print version ISSN 0004-2803

Abstract

COSTA, Sergio Renato Pais et al. Pelvic exenteration for T4 rectal cancer: a series of 15 ressectable cases. Arq. Gastroenterol. [online]. 2007, vol.44, n.4, pp. 284-288. ISSN 0004-2803.  http://dx.doi.org/10.1590/S0004-28032007000400002.

BACKGROUND: Pelvic exenteration is the best therapeutic choice for treatment of T4 rectal cancer. Although, this operation still presents considerable mortality and high morbidity. AIM: To report on a series of 15 patients with a T4 rectal cancer at a general hospital and describe the outcomes (morbidity, mortality and long-term survival) following pelvic exenteration. METHODS: Complete follow-up data were available on 15 patients who underwent pelvic exenteration for T4 rectal cancer between 1998 and 2006. These subjects comprised seven men and eight women with a mean age of 65 years. All of them presented serious incapacitating complaints. The surgical procedures included: infraelevator exenteration (n = 6), supraelevator exenteration (n = 4), posterior exenteration (n = 3) and, posterior exenteration plus partial cystectomy and ureterectomy (n = 2). RESULTS: The mean duration of surgery was 403 minutes (280-485). The mean blood loss was 1620 mL (300-4.800). The postoperative mortality was 6,66% (n = 1). The overall rate morbidity was 53,3% (n = 8). The pathological examination showed that all resections were R0. Lymph node involvement was present in four patients (26,66 %), and all of them died due to tumor recurrence. The overall 5-year survival rate was 35,7%. CONCLUSION: In spite of its aggressive nature and high morbidity, pelvic exenteration seems justified in rectal carcinoma when the disease extends to the urinary or genital tract. This procedure may offer long-term disease control.

Keywords : Pelvic exenteration; Rectal neoplasms.

        · abstract in Portuguese     · text in Portuguese     · pdf in Portuguese